Dubinsky M - Search Results

1

Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.

Kaur M, Panikkath D, Yan X, Liu Z, Berel D, Li D, Vasiliauskas EA, Ippoliti A, Dubinsky M, Shih DQ, Melmed GY, Haritunians T, Fleshner P, Targan SR, McGovern DP. Kaur M, et al. Among authors: dubinsky m. Inflamm Bowel Dis. 2016 Apr;22(4):862-9. doi: 10.1097/MIB.0000000000000705. Inflamm Bowel Dis. 2016. PMID: 26937622 Free PMC article.

2

Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.

Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Ruemmele FM, et al. Among authors: dubinsky m. Gastroenterology. 1998 Oct;115(4):822-9. doi: 10.1016/s0016-5085(98)70252-5. Gastroenterology. 1998. PMID: 9753483

3

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Théorêt Y, Seidman EG. Dubinsky MC, et al. Gastroenterology. 2000 Apr;118(4):705-13. doi: 10.1016/s0016-5085(00)70140-5. Gastroenterology. 2000. PMID: 10734022 Clinical Trial.

4

Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.

Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Dubinsky MC, et al. Am J Gastroenterol. 2001 Mar;96(3):758-65. doi: 10.1111/j.1572-0241.2001.03618.x. Am J Gastroenterol. 2001. PMID: 11280547

5

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.

Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Inflamm Bowel Dis. 2001 Aug;7(3):181-9. doi: 10.1097/00054725-200108000-00001. Inflamm Bowel Dis. 2001. PMID: 11515842 Clinical Trial.

6

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

Dubinsky MC, Yang H, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Gastroenterology. 2002 Apr;122(4):904-15. doi: 10.1053/gast.2002.32420. Gastroenterology. 2002. PMID: 11910342 Clinical Trial.

7

Treatment of Crohn's Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes.

Dubinsky MC, Fleshner PP. Dubinsky MC, et al. Curr Treat Options Gastroenterol. 2003 Jun;6(3):183-200. doi: 10.1007/s11938-003-0001-1. Curr Treat Options Gastroenterol. 2003. PMID: 12744819

8

Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.

Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Am J Gastroenterol. 2003 May;98(5):1058-63. doi: 10.1111/j.1572-0241.2003.07413.x. Am J Gastroenterol. 2003. PMID: 12809828

9

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients.

Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, Martin P, Vierling JM, Geller SA, Targan SR, Poordad FF. Dubinsky MC, et al. Gastroenterology. 2003 Aug;125(2):298-303. doi: 10.1016/s0016-5085(03)00938-7. Gastroenterology. 2003. PMID: 12891528

10

Monitoring of AZA/6-MP treatment in children with IBD is necessary.

Dubinsky MC. Dubinsky MC. Inflamm Bowel Dis. 2003 Nov;9(6):386-8; discussion 392-3. doi: 10.1097/00054725-200311000-00007. Inflamm Bowel Dis. 2003. PMID: 14671488 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page